Evidence map›Paper›PMID 37719833›Full record

ArticleJSES international2023

Subacromial injection of hydrolyzed collagen in the symptomatic treatment of rotator cuff tendinopathy: an observational multicentric prospective study on 71 patients.

Matteo Buda, Sabri Dlimi, Marco Parisi, Andrea Benoni, Gianluca Bisinella, Stefano Di Fabio

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JSES international, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matteo BudaDepartment of Orthopaedics and Trauma Surgery, Ospedali Riuniti Padova Sud, Monselice, (PD), Italy.
Sabri DlimiDepartment of Orthopaedics and Trauma Surgery, Poliambulatorio Arcella, Padova, Italy.
Marco ParisiDepartment of Orthopaedics and Trauma Surgery, San Martino Hospital of Belluno, ULSS1 Dolomiti, Belluno, Italy.
Andrea BenoniDepartment of Orthopaedics and Trauma Surgery, University of Verona, Verona, Italy.
Gianluca BisinellaDepartment of Orthopaedics and Trauma Surgery, Ospedali Riuniti Padova Sud, Monselice, (PD), Italy.
Stefano Di FabioDepartment of Orthopaedics and Trauma Surgery, San Martino Hospital of Belluno, ULSS1 Dolomiti, Belluno, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The purpose of the present observational multicentric prospective study was to evaluate the efficacy and safety of a new infiltration device (CHondroGrid, Bioteck S.p.A, Arcugnano, Italy) based on hydrolyzed collagen in the treatment of rotator cuff tendinopathy. Methods: Seventy-one patients (53.3 ± 11.6 years old) affected by rotator cuff tendinopathy were treated in 2021 with two subacromial injections of CHondroGrid at 13 ± 2.9 days apart. The outcomes measured were the visual analog scale (VAS) score (in movement, during the night, and at rest), the Constant Score, the Simple Shoulder Test, and patient satisfaction. The outcome variables were measured before each injection, at 1 month and at 6 months after the last injection. Results: The treatment was significantly effective from the first injection and up to the six-month follow-up. At the last follow-up, the VAS score on movement had improved by 71% ( Conclusions: CHondroGrid resulted in a safe and effective treatment in pain relief and for the functional recovery of rotator cuff tendinopathy.

Indexed as

Hydrolyzed collagenInfiltrative deviceNon-pharmacological therapyRotator cuffTendinopathyTendons

Identifiers

PMID37719833
PMCPMC10499841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.